Patient voices have helped secure the approval of a new drug designed to improve the lives of people affected by PH in Scotland.
The PHA UK has gained the support of its local MP to help drive change for people living with pulmonary hypertension.
PHocus2021 has been working hard to make patient voices heard in the drive for a newly licensed treatment to be made available to people with pulmonary hypertension (PH).
A survey to discover the real financial impact of pulmonary hypertension has been launched by the PHA UK, to help meet the aims of PHocus2021.
PRESS RELEASE: A rare disease that leaves people struggling to breathe will go under the spotlight during a dedicated awareness week in November. ‘PH Awareness Week 2017’ takes place from November 20th – 26th and will encourage people to find out more about pulmonary hypertension (PH), a serious condition that causes high blood pressure in […]
People diagnosed with pulmonary hypertension experience a significant reduction in their quality of life, research from the Pulmonary Hypertension Association (PHA UK) has found.
